Whereas miR200a was the predominant Akt1-regulated miRNA identified in breast cancer cells, this, however, was unchanged in the Akt-suppressed TRAMP prostates suggesting that the Akt1-regulated miRNAs in different cancer types may vary based on their origin and/or specific mutations that they hold. This evidence concerns the gene AKT1 and cancer.